{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:10:57Z","timestamp":1771510257131,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.diabet.2020.10.006","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T22:07:35Z","timestamp":1604527655000},"page":"101208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6360-9310","authenticated-orcid":false,"given":"Jun Young","family":"Do","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-4245","authenticated-orcid":false,"given":"Kyu Hyang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1023-0195","authenticated-orcid":false,"given":"Seok Hui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2020.10.006_bib0005","unstructured":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available at: https:\/\/covid19.who.int\/. [Accessed August 2020]."},{"key":"10.1016\/j.diabet.2020.10.006_bib0010","unstructured":"Korea Centers for Disease Control and Prevention. The updates on COVID-19 in Korea as of 6 August. Available at: https:\/\/www.cdc.go.kr\/board\/board.es?mid=a30402000000&bid=0030. [Accessed August 2020]."},{"key":"10.1016\/j.diabet.2020.10.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.26050","article-title":"Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis","author":"Tian","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.diabet.2020.10.006_bib0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabet.2020.05.001","article-title":"Patients with diabetes are at higher risk for severe illness from COVID-19","volume":"46","author":"Targher","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2020.10.006_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diabet.2020.05.008","article-title":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2020.10.006_bib0030","first-page":"S1262","article-title":"Metformin and COVID-19: from cellular mechanisms to reduced mortality","volume":"1","author":"Scheen","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2020.10.006_bib0035","article-title":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19","author":"Bramante","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.diabet.2020.10.006_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin treatment was associated with decreased mortality in covid-19 patients with diabetes in a retrospective analysis","volume":"103","author":"Luo","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.diabet.2020.10.006_bib0045","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2020.10.006_bib0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and covid-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2020.10.006_bib0055","unstructured":"#opendata4covid19. Available at: https:\/\/covid19data.hira.or.kr. [Accessed August 2020]."},{"key":"10.1016\/j.diabet.2020.10.006_bib0060","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial","volume":"366","author":"Granger","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2020.10.006_bib0065","first-page":"239","article-title":"Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations","volume":"12","author":"Bramley","year":"2006","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.diabet.2020.10.006_bib0070","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2020.10.006_bib0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.diabet.2020.10.006_bib0080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.diabet.2020.10.006_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1262-3636(07)70261-6","article-title":"Effect of metformin on survival rate in experimental sepsis","volume":"32","author":"Gras","year":"2006","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2020.10.006_bib0090","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1002\/dmrr.2975","article-title":"Is metformin poised for a second career as an antimicrobial?","volume":"34","author":"Malik","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2020.10.006_bib0095","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/resp.13486","article-title":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin","volume":"24","author":"Mendy","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.diabet.2020.10.006_bib0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12931-019-1035-9","article-title":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease","volume":"20","author":"Ho","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.diabet.2020.10.006_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00228-019-02786-y","article-title":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis","volume":"76","author":"Zhang","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.diabet.2020.10.006_bib0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S2213-8587(20)30021-8","article-title":"Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial","volume":"8","author":"Pernicova","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl. (1)","key":"10.1016\/j.diabet.2020.10.006_bib0115","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.2337\/dc19-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2020.10.006_bib0120","unstructured":"Korean Diabetes Association. Treatment Guideline for Diabetes. Available at: https:\/\/www.diabetes.or.kr\/pro\/publish\/guide.php?code=guide&number=735&mode=view. [Accessed August 2020]."},{"key":"10.1016\/j.diabet.2020.10.006_bib0125","doi-asserted-by":"crossref","first-page":"e4018","DOI":"10.1097\/MD.0000000000004018","article-title":"Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study","volume":"95","author":"Ko","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.diabet.2020.10.006_bib0130","unstructured":"ClinCalc.com Metformin hydrochloride-drug usage statistics, United States, 2007-2010. Available from: https:\/\/clincalc.com\/DrugStats\/Drugs\/MetforminHydrochloride. [Accessed September 2020]."}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363620301592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363620301592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:58:04Z","timestamp":1761130684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363620301592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1262363620301592"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2020.10.006","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2020.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101208"}}